4Meier P, Meier R, Blanc E. Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease [J]. Expert Rev Cardiovasc Ther, 2008, 6(7): 987-97.
5Meier P, Golshayan D, Blanc E, et al. Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD [ J ]. J Am Soc Nephrol, 2009, 20(6): 1368-84.
6Hou FF. Cardiovascular complication in patients with chronic renal disease[J]. Chin J Cardiol, 2004, 32(Suppl): 16.
7Vanholder R, Massy Z, Argiles A, et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality [J]. Nephrol Dial Transplant, 2005, 20(6): 1048-56.
8Stenvinkel P. Inflammatory and atherosclerotic interactions in the depleted uremic patient[J]. Blood Purif, 2002, 19(5): 53-61.
9Mallat Z, Ait-Oufella H, Tedgui A. Regulatory T cell responses: potential role in the control of atherosclerosis [J]. Curr Opin Lipidol, 2005, 16(5): 518-24.
10Gagnon RF, Gallimore B. Characterization of a mouse model of chronic uremia[J]. Urol Res, 1988, 16(2): 119-26.
